1. In Vivo
  2. >>ESG
  3. >>Diversity & Inclusion

BioBytes: Machine Learning Could Improve Clinical Trial Diversity

 
• By David Wild

With a growing focus on clinical trial diversity, companies are looking for ways to recruit from historically marginalized communities. Machine learning may help meet these diversity goals. 

Bio Bytes
• Source: Shutterstock

Welcome to In Vivo’s new AI-focused blog, BioBytes, providing news and insight on the growing role of artificial intelligence in biopharma.

Artificial intelligence is proving its value in drug discovery, but it also has a role in addressing issues of equity...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diversity & Inclusion

More from ESG

Global Regulator Action To Improve Diversity In Clinical Trials

 
• By Vibha Sharma

As efforts to improve diversity in clinical trials gain momentum globally, regulators in the UK, the EU, Canada, Australia and Japan were asked about their efforts to support representative enrolment. 

Providing The Balance Between Medtech Innovation And Providers’ Sustainability

 
• By Ashley Yeo

Royal Philips is at the forefront of the driving environmental sustainability along the Scope 1-2-3 chain. The company hosted a round table in Amsterdam to hear experiences from providers.

FDA Publishes Updated Roadmap For Advancing Women’s Health

 
• By Brian Bossetta

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.